Medical Consumables and Lab Consumables OEM Manufacturer
Medical Consumables and Lab Consumables OEM Manufacturer

News & Events

27 2019.08
Full text of the new “Drug Administration Law of the People's Republic of China”
City license. The transferee shall have the quality management, risk prevention and control, and liability compensation capabilities to ensure the safety, effectiveness, and quality controllability of...
10 2019.06
Proclamation of the “General Instructions on Human Gene Therapy Products (Draft)”
General Introduction to Gene Therapy Products for Human Use (Draft for Public Notice)OverviewGene therapy products are usually composed of vectors or delivery systems containing engineered gene constr...
29 2019.03
The General Office of the National Health Commission issued the Letter of Opinion on “Administrative Measures for the Clinical Research and Translational Use of Somatic Cell Therapy (Interim)
Chapter 1 General ProvisionsArticle 1 These Measures are formulated in accordance with the Drug Administration Law of the People's Republic of China and the Regulations on the Administration of Me...
07 2018.09
Announcement of “Regulations on Manufacturing Quality Management for Chimeric Antigen Receptor T Cell (CAR-T cell)-based Drug Products”
In recent years, immunotherapy has experienced a series of rapid developments. New immunotherapy technologies represented by specific adoptive immune cell therapy and immune checkpoint antibody therap...
05 2018.06
Notification of “CAR-T Cell Quality Control Testing Research and Non-clinical Study Considerations”
Chimeric antigen receptor T cells (CAR-T) refer to the transfer of genetic material with specific antigen recognition domains and T cell activation signals into T cells through gene modification techn...
13 2018.03
Considerations on “IND Application Studies and Application Materials for Cellular Therapy Products”
In recent years, tumor immunotherapy technology has made rapid progress, and gene-modified cell products represented by chimeric antigen receptor modified T cells (CAR-T) have entered the clinic one a...
28 2017.12
The Comprehensive Affairs Department of NMPA Issued the “Announcement on the Direct Reporting of Adverse Reactions by Marketing Authorization Holders (Draft for Comments)”
In order to implement the Opinions on Deepening the Reform of the Review and Approval System to Encourage Innovation in Drugs and Medical Devices (Office Letter [2017] No. 42) issued by the General Of...
12 2017.12
The Comprehensive Affairs Department of NMPA Issued the Announcement on “Technical Guideline for the Pharmaceutical Study and Evaluation of Cellular Therapy Products” (No. 216, 2017)
In recent years, with the continuous development of basic theories, technical means and clinical medical exploration and research such as stem cell therapy, immune cell therapy and gene editing, cell ...
19 2017.09
Announcement Notification of “Regulations on the Quality Management of Cell Bank Establishment”
In my country, the cell therapy industry is developing rapidly as a strategic emerging industry, and its growth hotspots cover all aspects from cell banks to cell preparation preparation, cell therapy...
06 2016.06
Notice of the General Office of the State Council on Issuing the “Pilot Plan on Drug Marketing Authorization Holder System”
According to the "Decision of the Standing Committee of the National People's Congress on Authorizing the State Council to Carry out Pilot Programs of Drug Marketing Authorization Holder Syst...
04 2015.11
The NPC Standing Committee’s Decision on Authorizing the State Council to Carry out the Pilot Drug Marketing Authorization Holder System in Some Places and Related Issues
In order to promote the reform of the drug review and approval system, encourage drug innovation, improve drug quality, and provide practical experience for further reform and improvement of the drug ...
18 2015.08
Opinions of the State Council on the Reform of the Review & Approval System for Drugs and Medical Devices
In recent years, my country's pharmaceutical industry has developed rapidly, and the quality and standards of drugs and medical devices have been continuously improved, which has better met the pu...